Home » Topics » BioWorld Science

BioWorld Science
RSS

Portage, NCI and Stimunity collaborate to advance STING agonists and anti-RAGE agents

April 26, 2022

Turnstone Biologics collaborates with University of Montreal for development of TIL therapy

April 26, 2022

Origo Biopharma discloses new TGFBR1 inhibitors

April 26, 2022

Jiangsu Chia Tai Tianqing Pharmaceutical researchers synthesize new AKT inhibitors

April 26, 2022

Shenzhen Salubris Pharmaceuticals presents GLP-1 receptor agonists

April 26, 2022

Duality Biologics divulges new ADCs for cancer

April 26, 2022

BeiGene patents new MAP4K1 inhibitors

April 26, 2022

Discovery of novel oridonin analogues as potent anticancer agents

April 26, 2022

ZLD-2218, a novel BRD4 inhibitor for the treatment of kidney fibrosis

April 26, 2022

TNIK as novel therapeutic target in lung squamous cell carcinoma

April 26, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.